Literature DB >> 23389655

What can we learn from inflammatory bowel disease in developing countries?

Sunny H Wong1, Siew C Ng.   

Abstract

Inflammatory bowel diseases occur due to an aberrant immune response to luminal antigens in genetically predisposed individuals. Although specific genetic loci have been identified underlying the predisposition, they have not fully explained the disease etiology. Striking epidemiological observations implicate the critical role of environmental influences on disease penetrance. The emergence of disease consistently observed as a society becomes modernized or developed may be attributed to westernization of diet, changing antibiotic use, or improved hygiene status. These factors are linked with changes in the gastrointestinal microbiota which, in turn, may affect development of the immune system and influence the risk of disease occurrence. Geographic variations within developing countries suggest that the strength of influence by risk factors in a society varies greatly. Studies of IBD in populations of developing countries where there are opportunities to prospectively collect changing exposure data over time may provide clues to the disease etiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389655     DOI: 10.1007/s11894-013-0313-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  132 in total

1.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

2.  Clinical features and natural history of ulcerative colitis in Korea.

Authors:  Sang Hyoung Park; Young Min Kim; Suk-Kyun Yang; Sai-Hui Kim; Jeong-Sik Byeon; Seung-Jae Myung; Yun Kyung Cho; Chang-Sik Yu; Kwi-Sook Choi; Jun-Won Chung; Benjamin Kim; Kee Don Choi; Jin-Ho Kim
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 4.  Positive natural selection in the human lineage.

Authors:  P C Sabeti; S F Schaffner; B Fry; J Lohmueller; P Varilly; O Shamovsky; A Palma; T S Mikkelsen; D Altshuler; E S Lander
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

5.  Crohn's disease after in-utero measles virus exposure.

Authors:  A Ekbom; P Daszak; W Kraaz; A J Wakefield
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

6.  Crohn's disease in Stockholm County during 1990-2001: an epidemiological update.

Authors:  Annika Lapidus
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 7.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Authors:  Martin Feller; Karin Huwiler; Roger Stephan; Ekkehardt Altpeter; Aijing Shang; Hansjakob Furrer; Gaby E Pfyffer; Thomas Jemmi; Andreas Baumgartner; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

8.  Extracolonic diagnoses in ulcerative colitis: an epidemiological study.

Authors:  U Monsén; J Sorstad; G Hellers; C Johansson
Journal:  Am J Gastroenterol       Date:  1990-06       Impact factor: 10.864

9.  Common NOD2 mutations are absent in patients with Crohn's disease in India.

Authors:  Srinivasan Pugazhendhi; Aneesh Amte; Ramadass Balamurugan; Venkataraman Subramanian; Balakrishnan S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2008 Sep-Oct

10.  Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality.

Authors:  Tatsuo Oriuchi; Nobuo Hiwatashi; Yoshitaka Kinouchi; Seiichi Takahashi; Sho Takagi; Kenichi Negoro; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more
  10 in total

1.  Evaluation of Home Polysomnography Findings, Quality of Sleep, and Fatigue in Inflammatory Bowel Disease: A Case Series.

Authors:  Deise Lun Paixão; Dalva Poyares; Marta Sevilh de Paula; Joselmo Willamy Duarte; Paula Midor Castelo; Orlando Ambrogini-Júnior; Sender Jankie Miszputen; Celina Tizuko Fujiyam Oshima; Jair Ribeir Chagas; Ana Paula Ribeir Paiotti
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

2.  Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.

Authors:  Angélica Cruz-Lebrón; Leticia D'argenio Garcia; Aarthi Talla; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Rafick-Pierre Sékaly; Karina Inacio Ladislau de Carvalho; Alan D Levine
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

3.  Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery.

Authors:  Roxana Zaharie; Alina Tantau; Florin Zaharie; Marcel Tantau; Liana Gheorghe; Cristian Gheorghe; Serban Gologan; Cristina Cijevschi; Anca Trifan; Daniela Dobru; Adrian Goldis; Gabriel Constantinescu; Razvan Iacob; Mircea Diculescu
Journal:  J Crohns Colitis       Date:  2015-11-20       Impact factor: 9.071

4.  Metabolomics activity screening of T cell-induced colitis reveals anti-inflammatory metabolites.

Authors:  J Rafael Montenegro-Burke; Bernard P Kok; Carlos Guijas; Xavier Domingo-Almenara; Clara Moon; Andrea Galmozzi; Seiya Kitamura; Lars Eckmann; Enrique Saez; Gary E Siuzdak; Dennis W Wolan
Journal:  Sci Signal       Date:  2021-09-28       Impact factor: 8.192

Review 5.  Classical and recent advances in the treatment of inflammatory bowel diseases.

Authors:  H Sales-Campos; P J Basso; V B F Alves; M T C Fonseca; G Bonfá; V Nardini; C R B Cardoso
Journal:  Braz J Med Biol Res       Date:  2014-11-28       Impact factor: 2.590

6.  The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population.

Authors:  Bruno César da Silva; Andre Castro Lyra; Carlos Maurício Cardeal Mendes; Camila Paula Oliveira Ribeiro; Sonyara Rauedys Oliveira Lisboa; Mariana Tinoco Lordello de Souza; Renata Cavalcanti Portela; Genoile Oliveira Santana
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

7.  Combined Dietary Anthocyanins, Flavonols, and Stilbenoids Alleviate Inflammatory Bowel Disease Symptoms in Mice.

Authors:  Aurelia Scarano; Eugenio Butelli; Stefania De Santis; Elisabetta Cavalcanti; Lionel Hill; Maria De Angelis; Giovanna Giovinazzo; Marcello Chieppa; Cathie Martin; Angelo Santino
Journal:  Front Nutr       Date:  2018-01-24

Review 8.  Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease.

Authors:  Ming Zhang; Kaiji Sun; Yujun Wu; Ying Yang; Patrick Tso; Zhenlong Wu
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

9.  Quantifying the effects of aging and urbanization on major gastrointestinal diseases to guide preventative strategies.

Authors:  Liu Hui
Journal:  BMC Gastroenterol       Date:  2018-10-03       Impact factor: 3.067

10.  Combined Signature of the Fecal Microbiome and Plasma Metabolome in Patients with Ulcerative Colitis.

Authors:  Meiling Sun; Bing Du; Yang Shi; Yue Lu; Yangyang Zhou; Bingrong Liu
Journal:  Med Sci Monit       Date:  2019-05-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.